Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis

Objectives We sought to understand the demographic and clinical factors associated with variations in longitudinal antibody response following completion of two-dose regiment of BNT162b2 vaccination.Design This study is a 10-month longitudinal cohort study of healthcare workers and serially measured...

Full description

Bibliographic Details
Main Authors: Brian Claggett, Sonia Sharma, Min Wu, Peter Chen, Gil Y Melmed, Nancy Sun, Susan Cheng, Joseph E Ebinger, Matthew Driver, Dermot P B McGovern, Kimia Sobhani, Mohit Jain, Sandy Joung, Yunxian Liu, Brittany Weber, Patrick G Botting, Yu Hung Kao, Briana Khuu, Timothy Wynter, Trevor-Trung Nguyen, Mona Alotaibi, John C Prostko, Edwin C Frias, James L Stewart, Helen S Goodridge, Stanley C Jordan, Justyna Fert-Bober, Jennifer E Van Eyk, Margo B Minissian, Moshe Arditi, Jonathan G Braun
Format: Article
Language:English
Published: BMJ Publishing Group 2022-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/5/e059994.full
_version_ 1827063406554775552
author Brian Claggett
Sonia Sharma
Min Wu
Peter Chen
Gil Y Melmed
Nancy Sun
Susan Cheng
Joseph E Ebinger
Matthew Driver
Dermot P B McGovern
Kimia Sobhani
Mohit Jain
Sandy Joung
Yunxian Liu
Brittany Weber
Patrick G Botting
Yu Hung Kao
Briana Khuu
Timothy Wynter
Trevor-Trung Nguyen
Mona Alotaibi
John C Prostko
Edwin C Frias
James L Stewart
Helen S Goodridge
Stanley C Jordan
Justyna Fert-Bober
Jennifer E Van Eyk
Margo B Minissian
Moshe Arditi
Jonathan G Braun
author_facet Brian Claggett
Sonia Sharma
Min Wu
Peter Chen
Gil Y Melmed
Nancy Sun
Susan Cheng
Joseph E Ebinger
Matthew Driver
Dermot P B McGovern
Kimia Sobhani
Mohit Jain
Sandy Joung
Yunxian Liu
Brittany Weber
Patrick G Botting
Yu Hung Kao
Briana Khuu
Timothy Wynter
Trevor-Trung Nguyen
Mona Alotaibi
John C Prostko
Edwin C Frias
James L Stewart
Helen S Goodridge
Stanley C Jordan
Justyna Fert-Bober
Jennifer E Van Eyk
Margo B Minissian
Moshe Arditi
Jonathan G Braun
author_sort Brian Claggett
collection DOAJ
description Objectives We sought to understand the demographic and clinical factors associated with variations in longitudinal antibody response following completion of two-dose regiment of BNT162b2 vaccination.Design This study is a 10-month longitudinal cohort study of healthcare workers and serially measured anti-spike protein IgG (IgG-S) antibody levels using mixed linear models to examine their associations with participant characteristics.Setting A large, multisite academic medical centre in Southern California, USA.Participants A total of 843 healthcare workers met inclusion criteria including completion of an initial two-dose course of BNT162b2 vaccination, complete clinical history and at least two blood samples for analysis. Patients had an average age of 45±13 years, were 70% female and 7% with prior SARS-CoV-2 infection.Results Vaccine-induced IgG-S levels remained in the positive range for 99.6% of individuals up to 10 months after initial two-dose vaccination. Prior SARS-CoV-2 infection was the primary correlate of sustained higher postvaccination IgG-S levels (partial R2=0.133), with a 1.74±0.11 SD higher IgG-S response (p<0.001). Female sex (beta 0.27±0.06, p<0.001), younger age (0.01±0.00, p<0.001) and absence of hypertension (0.17±0.08, p=0.003) were also associated with persistently higher IgG-S responses. Notably, prior SARS-CoV-2 infection augmented the associations of sex (−0.42 for male sex, p=0.08) and modified the associations of hypertension (1.17, p=0.001), such that infection-naïve individuals with hypertension had persistently lower IgG-S levels whereas prior infected individuals with hypertension exhibited higher IgG-S levels that remained augmented over time.Conclusions While the IgG-S antibody response remains in the positive range for up to 10 months following initial mRNA vaccination in most adults, determinants of sustained higher antibody levels include prior SARS-CoV-2 infection, female sex, younger age and absence of hypertension. Certain determinants of the longitudinal antibody response appear significantly modified by prior infection status. These findings offer insights regarding factors that may influence the ‘hybrid’ immunity conferred by natural infection combined with vaccination.
first_indexed 2025-03-19T22:30:45Z
format Article
id doaj.art-8780247aa4eb4c398b2d4cf8d46d9331
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2025-03-19T22:30:45Z
publishDate 2022-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-8780247aa4eb4c398b2d4cf8d46d93312024-10-17T12:50:16ZengBMJ Publishing GroupBMJ Open2044-60552022-05-0112510.1136/bmjopen-2021-059994Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysisBrian Claggett0Sonia Sharma1Min Wu2Peter Chen3Gil Y Melmed4Nancy Sun5Susan Cheng6Joseph E Ebinger7Matthew Driver8Dermot P B McGovern9Kimia Sobhani10Mohit Jain11Sandy Joung12Yunxian Liu13Brittany Weber14Patrick G Botting15Yu Hung Kao16Briana Khuu17Timothy Wynter18Trevor-Trung Nguyen19Mona Alotaibi20John C Prostko21Edwin C Frias22James L Stewart23Helen S Goodridge24Stanley C Jordan25Justyna Fert-Bober26Jennifer E Van Eyk27Margo B Minissian28Moshe Arditi29Jonathan G Braun302 Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts, USA8 La Jolla Institute for Allergy and Immunology, La Jolla, California, USA1The First Hospital of Jilin University, Jilin, ChinaDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA1 F. Widjaja Inflammatory Bowel Disease Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA3 Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA12 F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA13 Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA7 Department of Medicine, School of Medicine, University of California, San Diego, San Diego, California, USASmidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA2 Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA3 Division of Pulmonary and Critical Care Medicine, University of California San Diego, San Diego, California, USA4 Applied Research and Technology, Abbott Laboratories, Abbott Park, Illinois, USA4 Applied Research and Technology, Abbott Laboratories, Abbott Park, Illinois, USA4 Applied Research and Technology, Abbott Laboratories, Abbott Park, Illinois, USA5 Department of Biomedical Sciences, Research Division of Immunology, Cedars-Sinai Medical Center, Los Angeles, California, USA6 Transplant Immunology Laboratory and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA1 Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA11 Smidt Heart Institute; Department of Pediatrics, Division of Infectious Diseases and Immunology; Infectious and Immunologic Diseases Research Center (IIDRC); Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA12 F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USAObjectives We sought to understand the demographic and clinical factors associated with variations in longitudinal antibody response following completion of two-dose regiment of BNT162b2 vaccination.Design This study is a 10-month longitudinal cohort study of healthcare workers and serially measured anti-spike protein IgG (IgG-S) antibody levels using mixed linear models to examine their associations with participant characteristics.Setting A large, multisite academic medical centre in Southern California, USA.Participants A total of 843 healthcare workers met inclusion criteria including completion of an initial two-dose course of BNT162b2 vaccination, complete clinical history and at least two blood samples for analysis. Patients had an average age of 45±13 years, were 70% female and 7% with prior SARS-CoV-2 infection.Results Vaccine-induced IgG-S levels remained in the positive range for 99.6% of individuals up to 10 months after initial two-dose vaccination. Prior SARS-CoV-2 infection was the primary correlate of sustained higher postvaccination IgG-S levels (partial R2=0.133), with a 1.74±0.11 SD higher IgG-S response (p<0.001). Female sex (beta 0.27±0.06, p<0.001), younger age (0.01±0.00, p<0.001) and absence of hypertension (0.17±0.08, p=0.003) were also associated with persistently higher IgG-S responses. Notably, prior SARS-CoV-2 infection augmented the associations of sex (−0.42 for male sex, p=0.08) and modified the associations of hypertension (1.17, p=0.001), such that infection-naïve individuals with hypertension had persistently lower IgG-S levels whereas prior infected individuals with hypertension exhibited higher IgG-S levels that remained augmented over time.Conclusions While the IgG-S antibody response remains in the positive range for up to 10 months following initial mRNA vaccination in most adults, determinants of sustained higher antibody levels include prior SARS-CoV-2 infection, female sex, younger age and absence of hypertension. Certain determinants of the longitudinal antibody response appear significantly modified by prior infection status. These findings offer insights regarding factors that may influence the ‘hybrid’ immunity conferred by natural infection combined with vaccination.https://bmjopen.bmj.com/content/12/5/e059994.full
spellingShingle Brian Claggett
Sonia Sharma
Min Wu
Peter Chen
Gil Y Melmed
Nancy Sun
Susan Cheng
Joseph E Ebinger
Matthew Driver
Dermot P B McGovern
Kimia Sobhani
Mohit Jain
Sandy Joung
Yunxian Liu
Brittany Weber
Patrick G Botting
Yu Hung Kao
Briana Khuu
Timothy Wynter
Trevor-Trung Nguyen
Mona Alotaibi
John C Prostko
Edwin C Frias
James L Stewart
Helen S Goodridge
Stanley C Jordan
Justyna Fert-Bober
Jennifer E Van Eyk
Margo B Minissian
Moshe Arditi
Jonathan G Braun
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
BMJ Open
title Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
title_full Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
title_fullStr Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
title_full_unstemmed Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
title_short Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
title_sort demographic and clinical characteristics associated with variations in antibody response to bnt162b2 covid 19 vaccination among healthcare workers at an academic medical centre a longitudinal cohort analysis
url https://bmjopen.bmj.com/content/12/5/e059994.full
work_keys_str_mv AT brianclaggett demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT soniasharma demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT minwu demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT peterchen demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT gilymelmed demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT nancysun demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT susancheng demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT josepheebinger demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT matthewdriver demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT dermotpbmcgovern demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT kimiasobhani demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT mohitjain demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT sandyjoung demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT yunxianliu demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT brittanyweber demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT patrickgbotting demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT yuhungkao demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT brianakhuu demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT timothywynter demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT trevortrungnguyen demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT monaalotaibi demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT johncprostko demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT edwincfrias demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT jameslstewart demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT helensgoodridge demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT stanleycjordan demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT justynafertbober demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT jenniferevaneyk demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT margobminissian demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT moshearditi demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis
AT jonathangbraun demographicandclinicalcharacteristicsassociatedwithvariationsinantibodyresponsetobnt162b2covid19vaccinationamonghealthcareworkersatanacademicmedicalcentrealongitudinalcohortanalysis